Home/Filings/4/0001225208-09-003860
4//SEC Filing

PAUL DONOVAN 4

Accession 0001225208-09-003860

CIK 0000885725other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 4:07 PM ET

Size

16.3 KB

Accession

0001225208-09-003860

Insider Transaction Report

Form 4
Period: 2009-02-12
PAUL DONOVAN
SVP, Corporate Comm
Transactions
  • Tax Payment

    Common Stock

    2009-02-12$8.80/sh2,271$19,98519,041 total
  • Exercise/Conversion

    Common Stock

    2009-02-12+6,41418,835 total
  • Tax Payment

    Common Stock

    2009-02-12$8.80/sh1,516$13,34121,312 total
  • Exercise/Conversion

    Common Stock

    2009-02-12+3,99322,828 total
  • Exercise/Conversion

    Deferred Stock Units

    2009-02-123,99359,402 total
    Exercise: $0.00Common Stock (3,993 underlying)
  • Exercise/Conversion

    Deferred Stock Units

    2009-02-126,41452,988 total
    Exercise: $0.00Common Stock (6,414 underlying)
Footnotes (2)
  • [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  • [F2]Reflects multiple DSU awards with independent vesting schedules.

Issuer

BOSTON SCIENTIFIC CORP

CIK 0000885725

Entity typeother

Related Parties

1
  • filerCIK 0001209527

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:07 PM ET
Size
16.3 KB